IMPEDE, IMPEDE-FX or IMPEDE-FX RapidFill: Peripheral vascular embolization
Study summary
EMBO-PMS is a prospective, multicentre, registry study of the IMPEDE and IMPEDE-FX Embolization Plug Systems
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Study participant is ≥18 years of age
* Study participant is considered a candidate for arterial or venous embolization of the peripheral vasculature
Exclusion Criteria:
* Study participant has an inability to provide written informed consent
* Study participant/treatment outside of the approved study device labeling, instructions for use (IFU)
* Study participant is a prisoner or member of other vulnerable population
Primary outcome measure(s)
Safety - Rate of freedom from serious adverse events — 30 days Rate of freedom from serious adverse events related to the study devices and/or procedure, per review and adjudication by medical monitor
Efficacy - Rate of technical success (embolization of target vessel) — Immediately after the intervention Technical success, defined as embolization of the target area after deployment of the study device
Trial sites (10)
Facility
City
Region
Status
Universitätsklinikum Carl-Gustav-Carus an der Technischen Universität Dresden
Dresden
Germany
Universitätsklinikum Heidelberg
Heidelberg
Germany
Universitätsklinikum Schleswig-Holstein (Campus Kiel)
Kiel
Germany
UNIVERSITÄTSKLINIKUM LEIPZIG AöR
Leipzig
Germany
Klinikum München rechts der Isar
München
Germany
Klinikum Nürnberg
Nuremberg
Germany
Klinikum StuttGart
Stuttgart
Germany
Uniklinikum Würzburg
Würzburg
Germany
St George's Hospital (St George's University Hospitals NHS Foundation Trust)
London
United Kingdom
St Mary's Hospital (Imperial College Healthcare NHS Trust)
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.